Related Experiment Video
Updated: Jun 14, 2026

04:19
A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
Published on: May 10, 2022
Detecting and managing depression in type II diabetes: PHQ-9 is the answer!
1Hunter College, New York, NY, USA.
Summary
Adults with diabetes have higher rates of depression. The Patient Health Questionnaire (PHQ-9) is a key tool for screening and managing depression in these patients, improving diagnosis and treatment.
Area of Science:
- Medical Research
- Psychiatry
- Endocrinology
Background:
- Depressive disorders are more prevalent in adults with diabetes compared to the general population.
- Effective screening for depression is crucial for managing comorbid conditions in diabetic patients.
Purpose of the Study:
- To highlight the significance of the Patient Health Questionnaire (PHQ-9) in primary care settings.
- To emphasize the impact of PHQ-9 screening on the diagnosis and treatment of depression in adults with diabetes.
Main Methods:
- Review of existing evidence on depression rates in diabetic populations.
- Analysis of the role and utilization of the Patient Health Questionnaire (PHQ-9) in primary care.
Main Results:
- The Patient Health Questionnaire (PHQ-9) is the most commonly used instrument for major depression screening in primary care.
- Utilizing the PHQ-9 can significantly influence the initial diagnosis and subsequent treatment of co-occurring diabetes and depression.
Conclusions:
- The PHQ-9 is an essential tool for identifying and managing depression in adults with diabetes.
- Improved screening and diagnosis through PHQ-9 can lead to better patient outcomes for those with both conditions.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

